SynthesisPediatric surgery international2025
Long-term outcomes beyond childhood in patients treated for congenital diaphragmatic hernia- a systematic review.
Synthesis in Pediatric surgery international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Advancements in the management of congenital diaphragmatic hernia (CDH) have significantly improved survival rates, shifting the focus toward long-term outcomes in adult survivors. However, limited awareness of CDH sequelae among adult physicians complicates the transition from pediatric to adult care. This systematic review aims to provide a comprehensive evaluation of the most common long-term complications in CDH survivors aged 16 years and older following neonatal surgical repair. A literature search of PubMed, MEDLINE, EMBASE, Web of Science, and Cochrane Library was conducted according to PRISMA guidelines and registered on PROSPERO. Nineteen studies met inclusion criteria, encompassing 250 adult survivors (mean age: 22.1 years). Chronic lung disease was observed in 33% of patients, with 28% experiencing dyspnea during daily activities and exertion. Gastroesophageal reflux disease (GERD) was present in 45%, and severe scoliosis was identified in 2.4%. Quality of life was generally reported as good, though 30% experienced depression and lower scores in vitality and mental health domains. CDH survivors frequently encounter multisystem morbidities, including pulmonary, gastrointestinal, and musculoskeletal challenges. Structured transition programs and multidisciplinary follow-up are essential to address these needs and ensure continuity of care into adulthood. Further research is warranted to optimize outcomes and develop standardized protocols for this growing population.
Indexed as
Identifiers
40100453What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.